Vaccine trial aims to stop colon polyps before they become cancer
NCT ID NCT02134925
Summary
This study is testing an experimental vaccine designed to teach the body's immune system to attack and kill colon polyp cells. It aims to prevent these polyps, which can turn into colorectal cancer, from growing back after removal. About 110 people who recently had a large or high-risk polyp removed will receive either the real vaccine or a placebo shot to see if it reduces recurrence.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111, United States
-
Kansas City Veterans Affairs Medical Center
Kansas City, Missouri, 64128, United States
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
-
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107, United States
-
University of Pittsburgh Cancer Institute (UPCI)
Pittsburgh, Pennsylvania, 15232, United States
-
University of Puerto Rico
San Juan, 00936, Puerto Rico
Conditions
Explore the condition pages connected to this study.